Desonide foam: a review

Daniel Parish, Noah Scheinfeld (2008) Desonide foam: a review Drugs Today (Barc) (IF: 2) 44(1) 55-62

Abstract

Desonide foam is a newly approved topical corticosteroid preparation of 0.05% desonide. It has been shown effective compared with vehicle placebo in the treatment of mild-to-moderate atopic dermatitis in both pediatric and adult populations. Given the favorable safety profile of all other desonide preparations and their utility as a low potency corticosteroid, desonide foam promises to be a useful addition to the armamentarium, when other desonide vehicles might be less acceptable.(c) 2008 Prous Science, S.A.U. or its licensors.

Links

http://www.ncbi.nlm.nih.gov/pubmed/18301804
http://dx.doi.org/10.1358/dot.2008.44.1.1143847

Similar articles

Tools

Export to RIS